Literature DB >> 32170581

Tight Junction-Related CLDN5 and CLDN6 Genes, and Gap Junction-Related GJB6 and GJB7 Genes Are Somatically Mutated in Gastric and Colorectal Cancers.

Hyun Ji Son1, Chang Hyeok An2, Nam Jin Yoo1, Sug Hyung Lee3,4.   

Abstract

Tight junction and gap junction are major cell junctions that play important roles in cellular communication and structural integrity. Alterations of these junctions are known to be involved in cancer pathogenesis. Claudins and connexins are major tight and gap junction proteins, but genetic alterations of these genes have not been reported in gastric (GC) and colorectal cancers (CRC) with microsatellite instability (MSI). Claudin genes CLDN5 and CKDN6, and connexin genes GJB6 and GJB7 have mononucleotide repeats in the coding sequences that might be mutation targets in the cancers with MSI. We analyzed 79 GCs and 145 CRCs, and found CLDN5 frameshift mutations in 3 (3%) CRCs and 1 (2.9%) GC, CLDN6 frameshift mutations in 6 (6%) CRCs, GJB6 frameshift mutations in 5 (5%) CRCs and GJB7 frameshift mutation in one CRC (1%) with high MSI (MSI-H). We also analyzed intratumoral heterogeneity (ITH) of the frameshift mutations in 16 CRCs and found that CLDN6 and GJB6 frameshift mutations showed regional ITH in 2 (12.5%) and 2 (12.5%) cases, respectively. Our results show that CLDN5, CLDN6, GJB6 and GJB7 genes harbor not only frameshift mutations but also mutational ITH, which together may be features of GC and CRC with MSI-H. Based on the roles of cellular junctions in cancers, frameshift mutations of tight junction and gap junction genes might contribute to tumorigenesis by altering their functions in GC and CRC.

Entities:  

Keywords:  CLDN5; CLDN6; Cancer; GJB6; GJB7; Mutation

Mesh:

Substances:

Year:  2020        PMID: 32170581     DOI: 10.1007/s12253-020-00806-2

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  2 in total

1.  Claudin-6 increases SNAI1, NANOG and SOX2 gene expression in human gastric adenocarcinoma AGS cells.

Authors:  Priscila Anhel Medrano-Gonzálezl; Franklin Cruz-Villegas; Alejandro Alarcón Del Carmen; Luis Felipe Montaño; Erika Patricia Rendón-Huerta
Journal:  Mol Biol Rep       Date:  2022-09-28       Impact factor: 2.742

2.  Brief Research Report Regional Difference in TRAF2 and TRAF3 Gene Mutations in Colon Cancers.

Authors:  Seong Won Moon; Hyun Ji Son; Eun Ji Choi; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2021-04-14       Impact factor: 3.201

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.